Porton Pharma Solutions Ltd. is an internationally recognized pharmaceutical contract development and manufacturing organization (CDMO) in enabling our global clients to optimize drug development and manufacturing. We provide customer development and manufacturing services for small molecule APIs, TIDES and Biologics from pre-clinical to commercialization. As of June 30, 2023, we have a proven record for the delivery of more than 2600 projects and established cooperation with more than 800 global clients. With our 5000+ skilled employees working across 20+ sites around the globe, Porton is committed to becoming the most open, innovative and reliable pharmaceutical service platform in the world and enabling the public’s early access to good medicines. With over 5000 employees, Porton Pharma Solutions, a global company with R&D and GMP-compliant manufacturing facilities across US, EU and China, provides customer-centric innovative and reliable CDMO solutions for Small Molecules, Tides, Biologics, ADCs from pre-clinical to commercial.

A Customer-Centric, Innovative, and Reliable CDMO with Global Solutions